ANTI-HUMAN GLOBULIN (COOMBS) - ANVISA Registration 10310030196

Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10310030196 and manufactured by WAMA PRODUTOS PARA LABORATORIO LTDA. The registration is held by WAMA PRODUTOS PARA LABORATORIO LTDA with validity until Jun 25, 2028.

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIAMED GMBH, ORTHO CLINICAL DIAGNOSTICS, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.